News
ReNeuron's latest press releases
Regulatory Update. 14/05/09
Guildford, UK, 14 May 2009: ReNeuron Group plc (LSE: RENE.L) today provides a regulatory update regarding its ReN001 stem cell therapy for stroke. In …
Read articleThird closing of the placing. 14/05/09
Guildford, UK, 14 May 2009: ReNeuron Group plc (LSE: RENE.L) announced on 12 March 2009 its intention to raise up to £3 million via a placing of …
New data regarding ReNeuron's ReN001 stem cell line for stroke to be presented at US conference. 01/05/09
Guildford, UK, 1 May 2009: ReNeuron Group plc (LSE: RENE.L) today announces further data concerning the pre-clinical characterisation and mode of …
ReNeuron successfully automates its stem cell manufacturing process. 09/04/09
Guildford, UK, 9 April 2009: ReNeuron Group plc (LSE: RENE.L) today announces the publication of a paper in the journal Biotechnology Letters* …
Second closing of the placing. 07/04/09
Guildford, UK, 7 April 2009: ReNeuron Group plc (LSE: RENE.L) announced on 12 March 2009 its intention to raise up to £3 million via a placing …
ReNeuron announces positive pre-clinical data with lead stem cell line in peripheral arterial disease . 06/04/09
Guildford, UK, 6 April 2009: ReNeuron Group plc (LSE: RENE.L) today announces positive pre-clinical efficacy data with its lead CTX stem cell line in …
Result of EGM and first closing of the placing. 03/04/09
Guildford, UK, 3 April 2009: ReNeuron Group plc (LSE: RENE.L) announced on 12 March 2009 its intention to raise up to £3 million via a placing …
ReNeuron Announces Fundraising and Conversion of Loan Notes. 12/03/09
Guildford, UK, 12 March 2009: ReNeuron Group plc (LSE: RENE.L) announces that it proposes to raise up to £3 million via a placing of up to 100,…
<< 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 >>If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.
Top of page